ZNF25
gene geneOn this page
Also known as KOX19FLJ31890Zfp9
Summary
ZNF25 (zinc finger protein 25, HGNC:13043) is a protein-coding gene on chromosome 10p11.21, encoding Zinc finger protein 25 (P17030). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 219749 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 60 total
- MANE Select transcript:
NM_145011
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13043 |
| Approved symbol | ZNF25 |
| Name | zinc finger protein 25 |
| Location | 10p11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KOX19, FLJ31890, Zfp9 |
| Ensembl gene | ENSG00000175395 |
| Ensembl biotype | protein_coding |
| OMIM | 194528 |
| Entrez | 219749 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 10 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000302609, ENST00000374633, ENST00000467975, ENST00000897640, ENST00000897641, ENST00000897642, ENST00000897643, ENST00000897644, ENST00000963595, ENST00000963596, ENST00000963597, ENST00000963598
RefSeq mRNA: 19 — MANE Select: NM_145011
NM_001329647, NM_001329648, NM_001329649, NM_001329650, NM_001329651, NM_001329652, NM_001329653, NM_001329654, NM_001329655, NM_001329656, NM_001329657, NM_001329658, NM_001329659, NM_001329660, NM_001329661, NM_001329662, NM_001329663, NM_001329664, NM_145011
CCDS: CCDS7195
Canonical transcript exons
ENST00000302609 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001464116 | 37949573 | 37953195 |
| ENSE00001921356 | 37976506 | 37976647 |
| ENSE00003468135 | 37957420 | 37957546 |
| ENSE00003488787 | 37953695 | 37953758 |
| ENSE00003539721 | 37971708 | 37971807 |
| ENSE00003652868 | 37957020 | 37957115 |
Expression profiles
Bgee: expression breadth ubiquitous, 253 present calls, max score 97.07.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.0525 / max 186.5970, expressed in 1259 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 109127 | 4.0067 | 1250 |
| 109126 | 0.0459 | 11 |
Top tissues by expression
258 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| endothelial cell | CL:0000115 | 97.07 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 96.36 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 94.65 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 94.14 | gold quality |
| primary visual cortex | UBERON:0002436 | 93.70 | gold quality |
| vastus lateralis | UBERON:0001379 | 93.64 | gold quality |
| occipital lobe | UBERON:0002021 | 93.46 | gold quality |
| calcaneal tendon | UBERON:0003701 | 93.27 | gold quality |
| quadriceps femoris | UBERON:0001377 | 93.02 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 92.93 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 92.85 | gold quality |
| pons | UBERON:0000988 | 92.77 | gold quality |
| cortical plate | UBERON:0005343 | 92.58 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 92.25 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 91.85 | gold quality |
| tendon | UBERON:0000043 | 91.77 | gold quality |
| deltoid | UBERON:0001476 | 91.64 | gold quality |
| cerebellar vermis | UBERON:0004720 | 91.59 | gold quality |
| parietal lobe | UBERON:0001872 | 91.49 | gold quality |
| postcentral gyrus | UBERON:0002581 | 91.27 | gold quality |
| biceps brachii | UBERON:0001507 | 91.18 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 91.01 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 90.95 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 90.93 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 90.73 | gold quality |
| ganglionic eminence | UBERON:0004023 | 90.71 | gold quality |
| embryo | UBERON:0000922 | 90.70 | gold quality |
| prefrontal cortex | UBERON:0000451 | 90.59 | gold quality |
| frontal cortex | UBERON:0001870 | 90.21 | gold quality |
| frontal lobe | UBERON:0016525 | 90.21 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.56 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
123 targeting ZNF25, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3120-5P | 100.00 | 65.56 | 965 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-3667-3P | 99.99 | 67.17 | 1636 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-218-5P | 99.93 | 72.22 | 2103 |
Literature-anchored findings (GeneRIF, showing 1)
- This study shows that the uncharacterized transcription factor, ZNF25, is associated with differentiation of hMSC to osteoblasts. (PMID:27814695)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp9 | ENSMUSG00000072623 |
| rattus_norvegicus | Zfp9 | ENSRNOG00000006726 |
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)
Protein
Protein identifiers
Zinc finger protein 25 — P17030 (reviewed: P17030)
Alternative names: Zinc finger protein KOX19
All UniProt accessions (1): P17030
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P17030-1 | 1 | yes |
| P17030-2 | 2 |
RefSeq proteins (19): NP_001316576, NP_001316577, NP_001316578, NP_001316579, NP_001316580, NP_001316581, NP_001316582, NP_001316583, NP_001316584, NP_001316585, NP_001316586, NP_001316587, NP_001316588, NP_001316589, NP_001316590, NP_001316591, NP_001316592, NP_001316593, NP_659448* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050752 | C2H2-ZF_domain | Family |
Pfam: PF00096, PF01352
UniProt features (19 total): zinc finger region 12, sequence variant 3, splice variant 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P17030-F1 | 78.64 | 0.41 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 58 (showing top):
GTGCCTT_MIR506, chr10p11, CTGTTAC_MIR194, GCACTTT_MIR175P_MIR20A_MIR106A_MIR106B_MIR20B_MIR519D, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, FEV_TARGET_GENES, NKX2_2_TARGET_GENES, SALL4_TARGET_GENES, ZIM3_TARGET_GENES, ZNF8_TARGET_GENES, MIR106B_5P, MIR20A_5P, MIR106A_5P, MIR17_5P
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
462 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF25 | RASGEF1C | Q8N431 | 400 |
| ZNF25 | MTRNR2L7 | P0CJ74 | 370 |
| ZNF25 | BRD8 | Q9H0E9 | 367 |
| ZNF25 | ZNF608 | Q9ULD9 | 357 |
| ZNF25 | RANBP3L | Q86VV4 | 348 |
| ZNF25 | ZZZ3 | Q8IYH5 | 338 |
| ZNF25 | ZSWIM3 | Q96MP5 | 318 |
| ZNF25 | ZBTB21 | Q9ULJ3 | 316 |
| ZNF25 | ZNHIT1 | O43257 | 314 |
| ZNF25 | SMARCC2 | Q8TAQ2 | 314 |
| ZNF25 | ZFAND3 | Q9H8U3 | 306 |
| ZNF25 | PHYHIPL | Q96FC7 | 285 |
| ZNF25 | COMTD1 | Q86VU5 | 264 |
| ZNF25 | NFIX | Q14938 | 257 |
| ZNF25 | TAF1A | Q15573 | 255 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HEMGN | NPM1 | psi-mi:“MI:0914”(association) | 0.600 |
| ZNF25 | SCRN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF25 | ADRB2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SCRN1 | ZNF25 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (5): ZNF25 (Two-hybrid), ZNF25 (Two-hybrid), ZNF25 (Two-hybrid), ZNF25 (Affinity Capture-MS), ZNF25 (Affinity Capture-MS)
ESM2 similar proteins: A2RRD8, A6NHJ4, A6NK75, B4DU55, O75346, P0DPD5, P15621, P17030, P17039, P52737, Q0VGE8, Q14588, Q147U1, Q15928, Q2M3X9, Q3KNS6, Q494X3, Q4R6C2, Q5HYK9, Q5R5Q6, Q5R5S6, Q5REA0, Q5REK1, Q60585, Q61751, Q6ECI4, Q6P9Y7, Q6ZN19, Q6ZNA1, Q7Z3V5, Q86T29, Q86WZ6, Q8N141, Q8N7K0, Q8N9F8, Q8NA42, Q8NCK3, Q8NDQ6, Q8NEM1, Q8WV37
Diamond homologs: A0A1W2PQL4, A0JNB1, A0JPL0, A6NK53, A6QLU5, A6QPT6, A7MBI1, A8MT65, A8MUV8, A8MWA4, B2RXC5, B4DU55, B4DX44, E9PYI1, O14628, O75346, P0CH99, P0CI00, P17014, P17030, P17032, P17098, P51786, P85977, Q02386, Q06730, Q06732, Q0VAW7, Q12901, Q13360, Q14586, Q14588, Q14590, Q16587, Q2M3X9, Q2VY69, Q32M78, Q3ZCX4, Q49AA0, Q4R6J4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
60 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 56 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1417 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:37957114:ACC:A | acceptor_loss | 1.0000 |
| 10:37957115:CCTAT:C | acceptor_loss | 1.0000 |
| 10:37957116:C:CA | acceptor_loss | 1.0000 |
| 10:37957419:CCCA:C | donor_gain | 1.0000 |
| 10:37957422:A:AC | donor_gain | 1.0000 |
| 10:37957423:C:CC | donor_gain | 1.0000 |
| 10:37957458:T:TA | donor_gain | 1.0000 |
| 10:37971703:CTCA:C | donor_loss | 1.0000 |
| 10:37971704:TCA:T | donor_loss | 1.0000 |
| 10:37971705:CA:C | donor_loss | 1.0000 |
| 10:37971706:A:AG | donor_loss | 1.0000 |
| 10:37975035:A:AC | donor_gain | 1.0000 |
| 10:37975036:C:CC | donor_gain | 1.0000 |
| 10:37953756:CTT:C | acceptor_gain | 0.9900 |
| 10:37953759:C:CC | acceptor_gain | 0.9900 |
| 10:37957116:C:CC | acceptor_gain | 0.9900 |
| 10:37967957:C:CT | acceptor_gain | 0.9900 |
| 10:37970292:AC:A | donor_gain | 0.9900 |
| 10:37970293:CC:C | donor_gain | 0.9900 |
| 10:37971806:ACCT:A | acceptor_loss | 0.9900 |
| 10:37971807:CCTGT:C | acceptor_loss | 0.9900 |
| 10:37971808:C:CG | acceptor_loss | 0.9900 |
| 10:37971809:T:G | acceptor_loss | 0.9900 |
| 10:37975036:CT:C | donor_gain | 0.9900 |
| 10:37953757:TT:T | acceptor_gain | 0.9800 |
| 10:37953758:TC:T | acceptor_loss | 0.9800 |
| 10:37953759:CTACA:C | acceptor_loss | 0.9800 |
| 10:37953760:T:A | acceptor_loss | 0.9800 |
| 10:37957385:C:CT | donor_gain | 0.9800 |
| 10:37957386:T:TT | donor_gain | 0.9800 |
AlphaMissense
3047 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:37952361:A:C | F379L | 0.997 |
| 10:37952361:A:T | F379L | 0.997 |
| 10:37952363:A:G | F379L | 0.997 |
| 10:37952697:A:C | F267L | 0.997 |
| 10:37952697:A:T | F267L | 0.997 |
| 10:37952699:A:G | F267L | 0.997 |
| 10:37952680:A:G | L273P | 0.996 |
| 10:37952428:A:G | L357P | 0.995 |
| 10:37952497:C:G | R334P | 0.995 |
| 10:37952277:A:C | F407L | 0.994 |
| 10:37952277:A:T | F407L | 0.994 |
| 10:37952279:A:G | F407L | 0.994 |
| 10:37952445:A:C | F351L | 0.993 |
| 10:37952445:A:T | F351L | 0.993 |
| 10:37952447:A:G | F351L | 0.993 |
| 10:37952596:A:G | L301P | 0.993 |
| 10:37952529:G:C | F323L | 0.992 |
| 10:37952529:G:T | F323L | 0.992 |
| 10:37952531:A:G | F323L | 0.992 |
| 10:37952613:G:C | F295L | 0.992 |
| 10:37952613:G:T | F295L | 0.992 |
| 10:37952615:A:G | F295L | 0.992 |
| 10:37952332:T:G | Q389P | 0.991 |
| 10:37952764:A:G | L245P | 0.991 |
| 10:37952865:G:C | F211L | 0.991 |
| 10:37952865:G:T | F211L | 0.991 |
| 10:37952867:A:G | F211L | 0.991 |
| 10:37952272:T:G | Q409P | 0.990 |
| 10:37952848:A:G | L217P | 0.990 |
| 10:37952248:T:G | Q417P | 0.989 |
dbSNP variants (sampled 300 via entrez): RS1000270229 (10:37958111 A>G), RS1000271825 (10:37967009 A>G), RS1000301271 (10:37957883 T>C,G), RS1000302864 (10:37966706 A>T), RS1000350225 (10:37953607 T>C), RS1000423436 (10:37974505 A>C,G), RS1000542461 (10:37978274 G>A), RS1000606857 (10:37959845 G>A), RS1000863817 (10:37951589 T>C), RS1001187812 (10:37963803 T>C), RS1001226983 (10:37972659 A>T), RS1001397136 (10:37960900 T>A,C), RS1001514378 (10:37978566 T>C), RS1001629582 (10:37959792 T>C), RS1001662464 (10:37959467 C>T)
Disease associations
OMIM: gene MIM:194528 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005288_3 | Extrinsic epigenetic age acceleration | 1.000000e-13 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0000473 | epigenetic status |
| EFO:0022597 | aging |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression | 3 |
| Cyclosporine | increases expression | 3 |
| aristolochic acid I | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| 2-methyl-4-isothiazolin-3-one | decreases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| zinc chromate | increases abundance, increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| chromium hexavalent ion | increases abundance, increases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| abrine | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Fulvestrant | increases methylation | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Niclosamide | increases expression | 1 |
| Phthalic Acids | decreases methylation | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.